BG101408A - Аналози на кератиноцитния растежен фактор - Google Patents

Аналози на кератиноцитния растежен фактор

Info

Publication number
BG101408A
BG101408A BG101408A BG10140897A BG101408A BG 101408 A BG101408 A BG 101408A BG 101408 A BG101408 A BG 101408A BG 10140897 A BG10140897 A BG 10140897A BG 101408 A BG101408 A BG 101408A
Authority
BG
Bulgaria
Prior art keywords
growth factor
kgf
keratinotine
analysis
epithelial cell
Prior art date
Application number
BG101408A
Other languages
English (en)
Other versions
BG63167B1 (bg
Inventor
Charles Morris
William Kenney
Bao-Lu Chen
Erik Hsu
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of BG101408A publication Critical patent/BG101408A/bg
Publication of BG63167B1 publication Critical patent/BG63167B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретението се отнася до аналози на силен митоген на растежа на нефибробластни епителни клетки, кератиноцитен растежен фактор (KGF), модифициран допървите 24 N-крайни аминокиселини, където цистеиновите остатъци, съответстващи на позициите на аминокиселини 1 и 15 на KGF [позиции 32 и 46 на аминокиселини от SEQ ID NO:2, (съответно Cys1 и Cys15)],са заличени или заместени с друга аминокиселина. Изобретението се отнася и до молекули на нуклеинови киселини, които кодират такива аналози, и до методи за използването на такива аналози за стимулиране пролиферацията на нефибробластни епителни клетки.
BG101408A 1994-10-13 1997-04-11 Аналози на кератиноцитния растежен фактор BG63167B1 (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32334094A 1994-10-13 1994-10-13
US32347594A 1994-10-13 1994-10-13
US48782595A 1995-06-07 1995-06-07
PCT/IB1995/000971 WO1996011949A2 (en) 1994-10-13 1995-10-12 Analogs of keratinocyte growth factor

Publications (2)

Publication Number Publication Date
BG101408A true BG101408A (bg) 1997-12-30
BG63167B1 BG63167B1 (bg) 2001-05-31

Family

ID=27406268

Family Applications (2)

Application Number Title Priority Date Filing Date
BG101392A BG101392A (bg) 1994-10-13 1997-04-07 Метод за лечение на захарен диабет с използване на кератиноцитен растителен фактор
BG101408A BG63167B1 (bg) 1994-10-13 1997-04-11 Аналози на кератиноцитния растежен фактор

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG101392A BG101392A (bg) 1994-10-13 1997-04-07 Метод за лечение на захарен диабет с използване на кератиноцитен растителен фактор

Country Status (23)

Country Link
EP (2) EP0804479B1 (bg)
JP (2) JP4426646B2 (bg)
KR (1) KR100278597B1 (bg)
CN (1) CN1168678A (bg)
AT (2) ATE237633T1 (bg)
AU (1) AU3707795A (bg)
BG (2) BG101392A (bg)
BR (2) BR9509269A (bg)
CA (2) CA2201940C (bg)
CZ (3) CZ297329B6 (bg)
DE (2) DE69535264T2 (bg)
DK (2) DK0804479T3 (bg)
EE (2) EE9700225A (bg)
ES (2) ES2196082T3 (bg)
FI (2) FI971420A0 (bg)
HU (2) HUT78050A (bg)
NO (2) NO971566L (bg)
NZ (2) NZ505502A (bg)
PL (2) PL320484A1 (bg)
PT (2) PT785948E (bg)
SI (2) SI0785948T1 (bg)
SK (2) SK284534B6 (bg)
WO (2) WO1996011950A1 (bg)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0555205T3 (da) 1989-01-31 2001-03-05 Jeffrey S Rubin DNA, der koder for en væstfaktor, som er specifik for epitelceller
US7084119B2 (en) 1993-06-29 2006-08-01 Chiron Corporation Truncated keratinocyte growth factor (KGF) having increased biological activity
NZ266622A (en) 1993-06-29 1997-10-24 Chiron Corp Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates
DK0785949T3 (da) * 1994-10-13 2003-08-18 Amgen Inc Fremgangsmåde til oprensning af keratinocytvækstfaktorer
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
EP0822943B9 (en) * 1995-04-27 2007-02-28 Coöperatie Cosun U.A. Inulin derivatives
DE69728415T2 (de) * 1996-10-15 2004-08-12 Amgen Inc., Thousand Oaks Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
SI0935652T1 (en) * 1996-10-15 2004-06-30 Amgen Inc. Keratinocyte growth factor-2 products
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
EP1041996A4 (en) 1997-12-22 2003-05-14 Human Genome Sciences Inc KERATINOCYTE GROWTH FACTOR-2 FORMULATIONS
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6242666B1 (en) 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
AU775937B2 (en) * 1999-01-14 2004-08-19 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
WO2002062842A1 (en) * 2001-02-06 2002-08-15 Merck Patent Gmbh Modified keratinocyte growth factor (kgf) with reduced immunogenicity
MXPA04001526A (es) 2001-08-21 2004-05-31 Chiron Corp Composiciones de polipetidos kgf.
AU2007214362B2 (en) * 2001-08-21 2009-11-26 Novartis Vaccines And Diagnostics, Inc. KGF polypeptide compositions
MX2007006822A (es) 2004-12-15 2007-07-24 Amgen Inc Formulaciones terapeuticas para el factor de crecimiento de queratinocitos.
CN102242124B (zh) * 2010-05-10 2013-05-22 齐鲁制药有限公司 改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) * 2020-08-28 2022-09-05 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
CA1306456C (en) * 1988-07-27 1992-08-18 Marjan International Pty. Ltd. Carpet stretcher
DK0555205T3 (da) * 1989-01-31 2001-03-05 Jeffrey S Rubin DNA, der koder for en væstfaktor, som er specifik for epitelceller
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
HU220641B1 (hu) * 1993-03-26 2002-03-28 Amgen Inc. Keratinocita növekedési faktor alkalmazása
US5348563A (en) * 1993-06-29 1994-09-20 Honeywell Inc. Air purifying apparatus
NZ266622A (en) * 1993-06-29 1997-10-24 Chiron Corp Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates
GB9315501D0 (en) * 1993-07-27 1993-09-08 Ici Plc Surfactant compositions
WO1995003831A1 (en) * 1993-08-02 1995-02-09 Prizm Pharmaceuticals, Inc. Monogenous preparations of cytotoxic conjugates

Also Published As

Publication number Publication date
CZ98197A3 (cs) 1998-11-11
ES2273338T3 (es) 2007-05-01
EP0785948B1 (en) 2003-04-16
NO971566L (no) 1997-04-14
AU681546B2 (en) 1997-08-28
CA2201940A1 (en) 1996-04-25
EE9700225A (et) 1998-02-16
JP4216329B2 (ja) 2009-01-28
FI971420L (fi) 1997-04-04
ATE342278T1 (de) 2006-11-15
CA2202075A1 (en) 1996-04-25
NO971566D0 (no) 1997-04-04
SK45597A3 (en) 1999-02-11
NO318761B1 (no) 2005-05-02
DE69535264T2 (de) 2007-02-01
JPH10507193A (ja) 1998-07-14
BG101392A (bg) 1997-10-31
CN1168678A (zh) 1997-12-24
ES2196082T3 (es) 2003-12-16
HUT78058A (hu) 1999-07-28
CA2201940C (en) 2009-05-12
JP4426646B2 (ja) 2010-03-03
NZ505502A (en) 2005-01-28
WO1996011950A1 (en) 1996-04-25
EE03975B1 (et) 2003-02-17
PL182888B1 (pl) 2002-03-29
KR100278597B1 (ko) 2001-01-15
JPH10507080A (ja) 1998-07-14
HU226168B1 (en) 2008-05-28
EP0785948A1 (en) 1997-07-30
SK284534B6 (sk) 2005-06-02
BR9509269A (pt) 1997-12-23
DE69530403T2 (de) 2003-10-30
EE9700081A (et) 1997-10-15
PL320484A1 (en) 1997-09-29
PT785948E (pt) 2003-09-30
CZ105097A3 (cs) 1998-10-14
FI971536L (fi) 1997-06-09
DE69530403D1 (de) 2003-05-22
AU3707795A (en) 1996-05-06
CZ297329B6 (cs) 2006-11-15
PT804479E (pt) 2007-02-28
WO1996011949A3 (en) 1996-12-12
CA2202075C (en) 2003-12-09
SI0785948T1 (en) 2003-08-31
DK0785948T3 (da) 2003-08-04
NZ335109A (en) 2000-08-25
FI971420A7 (fi) 1997-04-04
EP0804479A1 (en) 1997-11-05
PL319784A1 (en) 1997-08-18
EP0804479B1 (en) 2006-10-11
AU3708395A (en) 1996-05-06
FI120040B (fi) 2009-06-15
NO971568D0 (no) 1997-04-04
BG63167B1 (bg) 2001-05-31
SK43197A3 (en) 1999-03-12
DE69535264D1 (de) 2006-11-23
NO971568L (no) 1997-06-12
CZ297328B6 (cs) 2006-11-15
DK0804479T3 (da) 2007-01-29
SI0804479T1 (sl) 2006-12-31
FI971536A0 (fi) 1997-04-11
BR9509329A (pt) 1997-10-14
HUT78050A (hu) 1999-07-28
ATE237633T1 (de) 2003-05-15
FI971420A0 (fi) 1997-04-04
WO1996011949A2 (en) 1996-04-25

Similar Documents

Publication Publication Date Title
WO1996011949A3 (en) Analogs of keratinocyte growth factor
KR880010130A (ko) 폴리 펩티드, dna 및 그의 용도
DE69738586D1 (de) Hohe expressionsrate von proteinen
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
ATE272109T1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
DE69132814D1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
DE69333346D1 (de) Neuartiges p- selectin ligandenprotein
PT785950E (pt) Analogos do factor de crescimento de queratinocitos
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
BR0309401A (pt) polinucleotìdeo isolado, vetor de expressão, célula cultivada, método para produzir polipeptìdeos, e um anticorpo para um polipeptìdeo, e, anticorpo
PT81418A (en) Process to obtain antibodies for human non-small lung cell carcinomas
EP0546074A4 (en) Genetic material encoding igfbp-5
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin
ATE160288T1 (de) Antikörper, ihre herstellung und verwendung
ATE263239T1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
ATE356831T1 (de) Neuer galaninrezeptor
EP0750040A3 (en) Macrophage stimulating protein variant and method for producing the same
ATE141947T1 (de) Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren
DK0828004T3 (da) Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen